← All stocks

BIO-RAD LABORATORIES, INC.

BIO Net selling
CIK 0000012208 #931 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$349.89K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$349.89K
2 of 2 sales
Net
−$349.89K
−$349.89K against sales at will

By person

15 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BARRY JAMES
EVP, President, LSG
$214.29K (1)
−$214.29K
2,025
0.008%
$499.17K
+1,282%
ENGELHARDT EVA ANETTE
EVP, President, CDG
$135.60K (1)
−$135.60K
1,828
0.007%
$450.68K
SCHWARTZ NORMAN D
Chairman & CEO
5,051,230
18.9%
$1.25B
+0.2%
COREY COLLEEN
EVP, Global Human Resources
19,550
0.073%
$4.82M
+5.8%
Crowley Michael
EVP, GBL Commercial Operations
8,171
0.031%
$2.01M
0.0%
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer
4,151
0.016%
$1.02M
+1,547%
EVRAN SEDAT
EVP, Global Supply Chain
3,603
0.013%
$888.31K
+1,051%
DiVincenzo Jonathan P.
President & COO
1,963
0.007%
$483.96K
Allison Schwartz
Director
1,734
0.006%
$427.50K
+32.9%
ENLOE COURTNEY C
EVP, General Counsel & Sec
1,652
0.006%
$407.23K
+5,640%
Mehta Rajat
EVP, GBL Commercial Operations
1,232
0.005%
$303.75K
+761.3%
Hinckley Greg K
Director
1,215
0.005%
$299.55K
+143.0%
PEI MELINDA LITHERLAND
Director
715
0.003%
$176.28K
EDWARDS JEFFREY L
Director
715
0.003%
$176.28K
PINKSTON ARNOLD A
Director
715
0.003%
$176.28K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 48,460
History held since 9 Sep 2016